BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Prognosis
4 results:

  • 1. Increased levels of xpa might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between ERCC1 and xpa expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
    Mendoza J; Martínez J; Hernández C; Pérez-Montiel D; Castro C; Fabián-Morales E; Santibáñez M; González-Barrios R; Díaz-Chávez J; Andonegui MA; Reynoso N; Oñate LF; Jiménez MA; Núñez M; Dyer R; Herrera LA
    Br J Cancer; 2013 Jul; 109(1):68-75. PubMed ID: 23807173
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
    Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
    J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
    Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
    Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.